Inhibition of p53 degradation by Mdm2 acetylation
- PMID: 15013777
- DOI: 10.1016/S0014-5793(04)00168-1
Inhibition of p53 degradation by Mdm2 acetylation
Abstract
Mdm2 is a RING finger E3 ubiquitin ligase, which promotes ubiquitination and proteasomal degradation of the p53 tumor suppressor protein. Acetylation of p53 regulates p53's transcriptional activity and inhibits Mdm2-mediated p53 ubiquitination and degradation. We now report that Mdm2 is also a target for acetylation. Mdm2 is acetylated in vitro by CREB-binding protein (CBP) and to a lesser extent by p300, but not by p300/CPB-associated factor. Acetylation occurs primarily within the RING finger domain of Mdm2. In vivo acetylation of Mdm2 was detected easily with CBP but not p300. Efficient in vivo acetylation required the preservation of the RING finger. An Mdm2 mutant (K466/467Q) mimicking acetylation is impaired in its ability to promote p53 ubiquitination, as well as Mdm2 autoubiquitination. Moreover, K466/467Q is defective in promoting p53 degradation in living cells. We thus suggest that acetyltransferases may modulate cellular p53 activity not only by modifying p53, but also by inactivating Mdm2.
Similar articles
-
MDMX inhibits the p300/CBP-mediated acetylation of p53.DNA Cell Biol. 2002 Jul;21(7):519-25. doi: 10.1089/104454902320219077. DNA Cell Biol. 2002. PMID: 12162806
-
Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.Biochemistry. 2003 Mar 4;42(8):2291-9. doi: 10.1021/bi0271291. Biochemistry. 2003. PMID: 12600196
-
MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.EMBO J. 2005 Sep 21;24(18):3279-90. doi: 10.1038/sj.emboj.7600791. Epub 2005 Aug 18. EMBO J. 2005. PMID: 16107876 Free PMC article.
-
p53 regulation: teamwork between RING domains of Mdm2 and MdmX.Cell Cycle. 2011 Dec 15;10(24):4225-9. doi: 10.4161/cc.10.24.18662. Epub 2011 Dec 15. Cell Cycle. 2011. PMID: 22134240 Review.
-
Unlocking the Mdm2-p53 loop: ubiquitin is the key.Cell Cycle. 2008 Feb 1;7(3):287-92. doi: 10.4161/cc.7.3.5358. Epub 2007 Nov 25. Cell Cycle. 2008. PMID: 18235222 Review.
Cited by
-
Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment.Front Cell Dev Biol. 2023 Jul 19;11:1236271. doi: 10.3389/fcell.2023.1236271. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37538397 Free PMC article.
-
hMOF induces cisplatin resistance of ovarian cancer by regulating the stability and expression of MDM2.Cell Death Discov. 2023 Jun 8;9(1):179. doi: 10.1038/s41420-023-01478-y. Cell Death Discov. 2023. PMID: 37291112 Free PMC article.
-
Acetylation, Phosphorylation, Ubiquitination (Oh My!): Following Post-Translational Modifications on the Ubiquitin Road.Biomolecules. 2022 Mar 18;12(3):467. doi: 10.3390/biom12030467. Biomolecules. 2022. PMID: 35327659 Free PMC article. Review.
-
Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells-Relevance for Understanding (Germ Cell) Tumorigenesis.Int J Mol Sci. 2021 May 20;22(10):5377. doi: 10.3390/ijms22105377. Int J Mol Sci. 2021. PMID: 34065345 Free PMC article. Review.
-
The roles and regulation of MDM2 and MDMX: it is not just about p53.Genes Dev. 2021 May 1;35(9-10):575-601. doi: 10.1101/gad.347872.120. Epub 2021 Apr 22. Genes Dev. 2021. PMID: 33888565 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous